R. L. Fisher
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study
.
Journal of Infectious Diseases.
2001
27
27
Total citations
1
Recent citation
2.08
Field Citation Ratio
0.4
Relative Citation Ratio
Contact
full name
R. L.
Fisher
Quick Info
Publications
Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science
